InvestorsHub Logo
Followers 3
Posts 803
Boards Moderated 0
Alias Born 02/07/2016

Re: None

Monday, 05/23/2022 9:03:20 AM

Monday, May 23, 2022 9:03:20 AM

Post# of 8555
SVB Leerink initiated coverage of Halozyme Therapeutics with a rating of Outperform and set a new price target of $52.00
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent HALO News